查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2009142

鎮痛藥市場規模、佔有率、趨勢和預測：按類型、藥物類別、給藥途徑、疼痛類型、應用和地區分類（2026-2034 年）

Analgesics Market Size, Share, Trends, and Forecast by Type, Drug Class, Route of Administration, Pain Type, Application, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 140 Pages | 商品交期: 2-3個工作天內

價格

2025年全球鎮痛藥市場規模為584億美元。展望未來，IMARC Group預測，該市場將在2026年至2034年間以3.73%的複合年成長率成長，到2034年達到812億美元。目前，北美市場主導地位，預計2025年將佔據超過32.8%的市場。推動該市場成長的主要因素包括慢性疼痛疾病盛行率的上升、全球老年人口的成長以及藥物製劑技術的顯著進步。此外，對非鴉片類鎮痛藥和非處方（OTC）鎮痛藥需求的成長也為該市場帶來了良好的發展前景。

人口老化以及神經病變疼痛、偏頭痛和關節炎等慢性疼痛疾病盛行率的上升正在推動鎮痛藥市場的發展。人們對疼痛管理的認知不斷提高，以及對有效非處方藥 (OTC) 和處方箋鎮痛藥的需求不斷成長，都促進了市場成長。藥物製劑的改進，例如合併療法和緩釋製劑，提高了患者的療效和依從性。例如，2024 年 5 月，路易斯安那州立大學新奧爾良健康科學中心 (LSU Health New Orleans) 開發了一種新型的非成癮性鎮痛藥，用於治療急性、慢性及神經性疼痛，並在 I 期臨床試驗中取得了令人鼓舞的結果。這項突破性成果實現了疼痛管理，且避免了鴉片類藥物相關的毒性，已獲得美國食品藥物管理局 (FDA) 的簡審類，將進行進一步的臨床開發。由於對鴉片類藥物成癮的擔憂，非鴉片類鎮痛藥的使用日益增多，這也進一步推動了市場的發展。

老年族群中慢性疼痛問題（例如關節炎、偏頭痛和術後疼痛）的日益普遍，正在推動美國鎮痛藥市場的發展。疼痛管理療法的改進也對市場擴張產生了正面影響。例如，2024年8月，Concentric Analgesics公司公佈了新型疼痛管理療法博卡辣椒素（bocacapsaicin）的令人鼓舞的數據。一項針對全膝關節置換術術和拇趾滑液囊炎切除術的II期臨床試驗證實，博卡辣椒素可在兩週內有效緩解疼痛并促進早期停用鴉片類藥物，凸顯了其革新術後疼痛管理的潛力。人們對疼痛管理方案的認知不斷提高，以及消費者對非處方止痛藥的偏好日益增強，都顯著推動了市場成長。鴉片類藥物危機及其相關法規正在加速向非鴉片類鎮痛藥的轉變，進一步刺激了對更安全替代療法的需求。

止痛藥市場趨勢

慢性病發生率增加

在全球範圍內，關節炎、癌症和糖尿病等慢性疾病的日益普遍，推動了對疼痛管理解決方案的需求不斷成長。根據美國疾病管制與預防中心（CDC）發布的數據，美國約有1.29億人患有至少一種主要慢性疾病，包括心臟病、癌症、糖尿病、肥胖和高血壓。此外，約42%的人口患有兩種或兩種以上的慢性疾病，12%的人口患有至少五種慢性疾病。隨著全球人口老化，慢性疼痛疾病的發生率不斷上升，因此亟需有效的止痛計畫。如今，老年人更容易患上這些慢性疾病，而這些疾病往往伴隨持續性疼痛。

對非鴉片類鎮痛藥的需求不斷成長

鴉片類藥物危機及其高成癮和濫用風險，促使人們越來越傾向於使用非鴉片類止痛藥進行更安全的疼痛管理。非類固醇消炎劑（NSAIDs）和對乙醯胺酚等非鴉片類藥物因其風險較低而日益受到歡迎。例如，2024年1月，VX-548在兩項大型臨床試驗中顯示出令人鼓舞的結果，與安慰劑相比，該藥能顯著減輕術後疼痛，且副作用極小。 Vertex公司計劃向美國食品藥物管理局（FDA）申請核准該藥用於治療中度至重度急性疼痛。這一結果為在持續的鴉片類藥物危機中尋找替代成癮性鴉片類藥物的希望帶來了曙光。這些解決方案對多種類型的疼痛有效，並為急性和慢性疼痛管理提供了更安全的選擇。這種轉變正在推動非鴉片類鎮痛解決方案的創新和市場成長，以滿足人們對更安全治療方法的需求。

非處方止痛藥使用量增加

由於非處方止痛藥易於取得且電子商務蓬勃發展，因此被廣泛用作自我治療。這些非處方藥包括非類固醇消炎劑（NSAIDs）、對乙醯氨基酚及其組合藥物，可方便地緩解多種症狀。例如，2024年4月，Glenmark Pharmaceuticals公司獲得了美國食品藥物管理局（FDA）對其對乙醯胺酚乙醯胺酚和Ibuprofen片劑非專利藥的核准。該公司生產的藥品（Advil 2 Dual Action的非專利藥）預計將透過其美國子公司Glenmark Therapeutics在美國市場銷售。網路藥局的擴張使得非處方止痛藥更容易獲得並被廣泛使用。無需處方箋即可購買這些藥物，有助於消費者有效、快速地控制疼痛，從而推動了非處方止痛藥市場的成長。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球止痛藥市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場區隔：按類型
  • 市場區隔：依藥物類別分類
  • 市場區隔：依給藥途徑
  • 市場區隔：依疼痛類型分類
  • 市場區隔：按應用領域
  • 市場區隔：按地區
  • 市場預測

第6章 市場區隔：依類型

  • 處方箋
  • 非處方藥

第7章 市場區隔：依藥物類別分類

  • 鴉片類藥物
  • NSAID
  • 其他

第8章 市場區隔：依給藥途徑

  • 口服
  • 腸外
  • 外用
  • 經皮
  • 直腸

第9章 市場區隔：依疼痛類型分類

  • 肌肉骨骼系統
  • 外科手術/創傷
  • 癌症
  • 神經病變
  • 偏頭痛
  • 產科
  • 纖維肌痛
  • 燒燙傷疼痛
  • 牙科和臉部護理
  • 兒童
  • 其他

第10章 市場區隔：依應用領域分類

  • 內部的
  • 外部的

第11章 市場區隔：按地區分類

  • 北美洲
  • 歐洲
  • 亞太地區
  • 中東和非洲
  • 拉丁美洲

第12章 SWOT 分析

第13章：價值鏈分析

第14章：波特五力分析

第15章：價格分析

  • 價格指標
  • 價格結構
  • 利潤分析

第16章 競爭格局

  • 市場結構
  • 主要企業
  • 主要企業簡介
    • Bayer AG
    • Novartis International AG
    • GlaxoSmithKline PLC
    • Pfizer Inc.
    • Johnson & Johnson Pvt. Ltd.
    • Reckitt Benckiser（RB）Group PLC
    • Endo Pharmaceuticals PLC
    • Bristol-Myers Squibb Company
    • Eli Lilly and Company
    • Sanofi SA
Product Code: SR112026A1138

The global analgesics market size was valued at USD 58.4 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 81.2 Billion by 2034, exhibiting a CAGR of 3.73% during 2026-2034. North America currently dominates the market, holding a significant market share of over 32.8% in 2025 . The market is mainly driven by the rising prevalence of chronic pain conditions, an increasing global geriatric population, and significant technological advancements in drug formulations. There is also a growing demand for non-opioid and over-the-counter (OTC) pain relievers which creates a positive outlook for the market.

The growing number of elderly people and the prevalence of chronic pain disorders such neuropathic pain, migraines, and arthritis are driving the analgesics market. Growing awareness about pain management and the demand for effective OTC and prescription pain relief solutions contribute to market growth. Improvements in medication formulations, such as combination and extended-release treatments, improve patient efficacy and compliance. For instance, in May 2024, LSU Health New Orleans developed a novel and non-addictive painkiller for acute, chronic, and neuropathic pain indicating positive outcomes in Phase 1 trials. The breakthrough addresses pain management without the toxicity associated with opioids receiving FDA Fast Track designation for further clinical development. The rising adoption of non-opioid analgesics due to concerns over opioid addiction further boosts the market.

The increased prevalence of chronic pain problems, such as arthritis, migraines, and post-surgical pain, among the elderly population is driving the analgesics market in the United States. Improvements in pain management treatments are also favorably influencing the market's expansion. For instance, in August 2024, Concentric Analgesics presented promising data on vocacapsaicin a novel pain management therapy. Phase 2 trials for total knee arthroplasty and bunionectomy showed two weeks of effective pain relief and earlier opioid cessation highlighting vocacapsaicin's potential to revolutionize postoperative pain management. Rising consumer preference for OTC pain relievers fueled by increasing awareness of pain management options significantly boosts market growth. The ongoing shift towards non-opioid analgesics due to the opioid crisis and associated regulations further accelerates demand for safer alternatives.

ANALGESICS MARKET TRENDS

Increasing Incidence of Chronic Conditions

The increasing incidence of several chronic conditions such as arthritis, cancer, and diabetes throughout the world is fueling increased demand for solutions to pain management. As estimated by the data published by the Centers for Disease Control and Prevention about 129,000,000 people in the United States suffer from at least one major chronic condition including heart disease, cancer, diabetes, obesity, and hypertension. In addition to this, approximately 42% of the total population has more than two or more chronic diseases and 12% of the population is suffering from at least five chronic diseases. As the global population ages the incidence of chronic pain conditions is on the rise which necessitates effective analgesic options. Nowadays older adults are more prone to developing these chronic conditions which often come with persistent pain.

Increasing Demand for Non-Opioid Analgesics

The opioid crisis with high addiction and abuse rates has shifted preference towards non-opioid analgesics for safer pain management. Non-opioid options like nonsteroidal anti-inflammatory drugs (NSAIDs) and acetaminophen are increasingly popular due to their lower risk profiles. For instance, in January 2024, VX-548 demonstrated positive results in two major clinical trials showing significant pain relief after surgery compared to a placebo with few side effects. Vertex plans to seek FDA approval for the drug in treating moderate-to-severe acute pain. The results bring hope for an alternative to addictive opioid medications amidst the ongoing opioid crisis. These solutions are effective for different types of pain conditions offering a safer alternative for the management of acute and chronic pains. This shift is driving innovation and market growth in non-opioid solutions for pain relief which addresses the requirement for safer alternatives of therapy.

Rise in Use of OTC Analgesics

OTC analgesics are widely used for self-medication, as they are easily accessible, and the advent of e-commerce. These over-the-counter options which consist of NSAIDs (nonsteroidal anti-inflammatory drugs), acetaminophen, and combination products provide easy relief for many conditions. For instance, in April 2024, Glenmark Pharmaceuticals obtained USFDA approval for its generic Acetaminophen and Ibuprofen tablets. The company's drug - a generic version of Advil 2 Dual Action, will be distributed in the US market by Glenmark Therapeutics Inc, USA. OTC analgesics are widely used because it is now easy to get them due to the expansion of internet pharmacies. The availability of these drugs without a prescription helps consumers manage pain effectively and promptly, thus driving the growth of the OTC analgesics market.

ANALGESICS INDUSTRY SEGMENTATION:

Analysis by Type:

  • Prescription
  • Over the counter (OTC)

Prescription analgesics segment leads the market with around 70.0% market share in 2025. Prescription analgesics holds the largest market share because of their efficacy in relief of moderate to severe and chronic pain including postoperative pain, cancer pain, and severe arthritis. These medications including opioids and other potent pain relievers are necessary for conditions which other medications cannot effectively treat. The stringent regulation and physician supervision associated with prescription analgesics ensure appropriate use, driving their demand. Advancements in personalized medicine and targeted therapies contribute to the growth of prescription analgesics within the market.

Analysis by Drug Class:

  • Opioids
  • NSAIDs
  • Others

Opioids segment leads the market with around 52.0% market share in 2025. Opioids dominate the market share of analgesics since they remain the most effective in controlling extreme and chronic pain. The opioids include morphine, oxycodone, and fentanyl which help in managing severe pain during and after operations, such as cancer-related, and major injury pain. Despite the significant concerns over addiction and abuse, the medical necessity for potent pain relief in specific conditions ensures the continued demand for opioids. Regulatory efforts to control misuse and advancements in formulation to reduce addiction potential are shaping the market. Additionally, ongoing research into safer opioid alternatives and combination therapies further underscores the dominant position of opioids in the analgesics market.

Analysis by Route of Administration:

  • Oral
  • Parenteral
  • Topical
  • Transdermal
  • Rectal

Oral leads the market with around 48.7% market share in 2025. Oral analgesics represent the leading segment in the analgesics market due to their convenience, ease of administration, and wide availability. These are in the form of tablets, capsules, and liquid and are preferred in different sorts of pains ranging from headaches to even moderate post-operative pains. This availability of over-the-counter oral solid drugs such as acetaminophen and ibuprofen plays a major role in the segment growth. Advancements in oral drug formulations such as extended-release tablets enhance patient compliance and effectiveness, further solidifying the leadership of oral analgesics in the market.

Analysis by Pain Type:

  • Musculoskeletal
  • Surgical and Trauma
  • Cancer
  • Neuropathic
  • Migraine
  • Obstetrical
  • Fibromyalgia
  • Pain due to Burns
  • Dental/Facial
  • Pediatric
  • Others

Musculoskeletal pain management exhibits a clear dominance in the analgesics market due to the high prevalence of conditions such as arthritis, back pain, and sports injuries. These conditions are widespread among the aging population and active individuals, driving significant demand for effective pain relief. Both prescription and over-the-counter analgesics are extensively used to manage musculoskeletal pain making it a critical segment within the market. The ongoing research and development in targeting specific pain pathways and improving drug formulations further bolsters this dominance. The rise in sedentary lifestyles and increasing awareness of pain management options contribute to the sustained growth of this segment.

Analysis by Application:

  • Internal
  • External

Internal application of analgesics relates to the medication taken orally as well as administered through injection within the body, which includes managing pain from the inside. Thus, it includes tablets, capsules, and liquids for internal application administration, along with intravenous and intramuscular injections. All these conditions include chronic pain, post-operative pain, and other acute severe pains. Hence, internal applications are a sizeable market segment for analgesics mainly driven by their efficiency in providing systemic pain relief.

External application of analgesics: The topical preparations in the form of creams, gels, sprays, and patches applied on the skin surface are examples of external application of analgesics. These are more effective in the treatment of localized pain conditions such as muscle strain, joint pain, and minor injuries. These have the added advantage of site-specific therapy with minimal systemic side effects. Patients prefer this for non-invasive pain management. These non-systemic treatment preferences and progress in topical drug delivery systems propel the popularity of topical applications within the analgesics market.

Regional Analysis

  • Asia Pacific
  • North America
  • Europe
  • Middle East and Africa
  • Latin America

In 2025, North America accounted for the largest market share of over 32.8%. North America leads the analgesics market, accounting for the largest market share due to high healthcare expenditure, advanced medical infrastructure, and a high prevalence of chronic pain conditions. According to a report published by the Centers for Medicare & Medicaid Services, U.S. healthcare spending grew 4.1% in 2022 reaching $4.5 trillion or $13,493 per person. As a share of the nation's Gross Domestic Product, health spending accounted for 17.3%. The region's robust regulatory environment ensures the availability of prescription as well as over-the-counter analgesics. The ongoing opioid crisis has encouraged the development and adoption of non-opioid pain relief alternatives. The presence of major pharmaceutical companies and continuous research and development activities further strengthen North America's leading position in the analgesics market.

KEY REGIONAL TAKEAWAYS:

UNITED STATES ANALGESICS MARKET ANALYSIS

In 2025, the United States captured 90.80% of revenue in the North American market. This is because more patients are suffering from chronic diseases than before, which, coupled with enhanced methods of handling pain, enhances the uptake of analgesics in the United States. Arthritis is among the common causes of chronic pain and as per the CDC it affects 58.5 million adults or 23.7% of the population, the conditions are more common in the female sex, and the aged population. In addition, growing numbers of surgeries also contribute to the increasing demand for relief from pain. The National Center for Biotechnology Information estimates approximately 310 million major surgeries that occur annually of which around 40-50 million occur in the U.S. This clearly explains the demand for effective post-surgical pain management. The opioid crisis is yet another factor ruling the market. The U.S. FDA has initiated significant efforts in February 2022 to create non-addictive opioids. This has improved the prospects for safer pain management. These regulatory initiatives are likely to enhance the demand for prescription and over-the-counter analgesics and will drive sustained growth in the market over time.

EUROPE ANALGESICS MARKET ANALYSIS

The growing elderly population in Europe is a significant factor driving increased demand for analgesics as older people are more prone to chronic pain and associated health conditions. In 2020, 21% of the European population, or 94.7 million people, were 65 years of age or older. This age group according to the European Commission constitutes a fifth of the population but represents over 62% of new cancer diagnoses at 1.7 million and 76% of cancer-related deaths at 0.98 million. This clearly indicates a growing need for effective pain management solutions particularly concerning cancer-related pain in the elderly population. Another significant driver of the need for analgesics includes neuropathic pain that affects 7-8% of the European population. Prescription and over the counter analgesics are in high demand as more patients are suffering from cancer and neuropathic pain that continues to increase. A change in demographics and growth in the burden of the conditions causing pain will continue to promote the market growth of analgesics in Europe.

ASIA PACIFIC ANALGESICS MARKET ANALYSIS

The increasing rate of incidence of cancer in Asia has been one of the reasons for driving the analgesics market in the region. In 2020, the reported cancer incidence rate was 169.1 per 100,000 people, accounting for nearly 49.3% of the global cases. Lung cancer accounted for 13.8%, breast cancer accounted for 10.8% and colorectal cancer accounted for 10.6% of the most common types in the region as per an industry report. This situation presents a significant demand for effective pain management solutions particularly given the rising rates of cancer which are predominantly observed in the elderly population.

The increasing incidence of cancer is thereby driving a higher demand for prescription as well as over-the-counter analgesics, which are significant for both acute and chronic pain management. Rising population and prevalence of cancer will continue to fuel demand for pain relief options to drive growth in the market for analgesics in the Asia-Pacific region and ensure steady market growth over the next few years.

LATIN AMERICA ANALGESICS MARKET ANALYSIS

The aging population is a key driving factor for the growing demand for analgesics in Latin America and the Caribbean. According to an industry report, 2022 recorded 88.6 million people who were 60 years of age or older hence constituting 13.4% of the overall population and this portion is projected to increase by 2030 to about 16.5%. As the elderly population grows so does the demand for pain management as the elderly are even more susceptible to chronic pain and other related health problems.

Moreover, the incidence of cancer is increasing, especially cervical cancer, raising the demand for pain relief further. The Pan American Health Organization reports that over 56,000 women have been diagnosed with cervical cancer in the region killing over 28,000. With cancer cases burgeoning, especially among the geriatric population the pressure to seek prescription or non-prescription pain relief also will continue to rise. The shifting demographic balance and rising cancer burden will provide impetus to the Latin America analgesics market going forward.

MIDDLE EAST AND AFRICA ANALGESICS MARKET ANALYSIS

One of the key factors propelling the analgesics market in the Middle East and Africa (MEA) region is the rising prevalence of osteoarthritis. The age-standardized prevalence of OA in MENA was reported to be 5,342.8 per 100,000 people in 2019 according to the National Institutes of Health (NIH). The growing need for efficient pain management options is significantly impacted by osteoarthritis, which is a common source of chronic pain in the aged population.

With an aging population in MEA and an increase in chronic conditions, the need for analgesics prescription as well as over-the-counter medications is also on the rise. Osteoarthritis causes continuous pain in the joints and leads to disability compelling people to look for relief from the condition. The above demographic trend in combination with an overall rise in chronic pain conditions is also expected to drive further demand for analgesics in the Middle East and Africa thereby facilitating further growth in the market.

COMPETITIVE LANDSCAPE:

The analgesics market is highly competitive with major pharmaceutical companies like Pfizer, Johnson & Johnson, and GlaxoSmithKline leading the industry. These companies invest heavily in research and development to introduce new and effective pain relief formulations including non-opioid alternatives and advanced drug delivery systems. For instance, in January 2024, Vertex Pharmaceuticals released positive results from two large clinical trials of its non-opioid painkiller VX-548 which significantly reduces post-surgery pain compared to a placebo. The market also sees significant competition from generic drug manufacturers which offer cost-effective alternatives to branded medications. Additionally, emerging players focusing on natural and herbal analgesics are gaining traction. Strategic collaborations, mergers and acquisitions are common as companies seek to expand their product portfolios and market reach intensifying the competitive landscape in the analgesics market.

The report provides a comprehensive analysis of the competitive landscape in the analgesics market with detailed profiles of all major companies, including:

  • Bayer AG
  • Novartis International AG
  • GlaxoSmithKline PLC
  • Pfizer Inc.
  • Johnson & Johnson Pvt. Ltd.
  • Reckitt Benckiser (RB) Group PLC
  • Endo Pharmaceuticals PLC
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • Sanofi SA

KEY QUESTIONS ANSWERED IN THIS REPORT

1. How big is the analgesics market?

2. What is the future outlook of analgesics market?

3. What are the key factors driving the analgesics market?

4. Which region accounts for the largest analgesics market share?

5. Which are the leading companies in the global analgesics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Analgesics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Type
  • 5.5 Market Breakup by Drug Class
  • 5.6 Market Breakup by Route of Administration
  • 5.7 Market Breakup by Pain Type
  • 5.8 Market Breakup by Application
  • 5.9 Market Breakup by Region
  • 5.10 Market Forecast

6 Market Breakup by Type

  • 6.1 Prescription
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Over the counter (OTC)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Drug Class

  • 7.1 Opioids
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 NSAID
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Route of Administration

  • 8.1 Oral
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Parenteral
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Topical
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Transdermal
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Rectal
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Pain Type

  • 9.1 Musculoskeletal
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Surgical and Trauma
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Cancer
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Neuropathic
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Migraine
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast
  • 9.6 Obstetrical
    • 9.6.1 Market Trends
    • 9.6.2 Market Forecast
  • 9.7 Fibromyalgia
    • 9.7.1 Market Trends
    • 9.7.2 Market Forecast
  • 9.8 Pain due to Burns
    • 9.8.1 Market Trends
    • 9.8.2 Market Forecast
  • 9.9 Dental/Facial
    • 9.9.1 Market Trends
    • 9.9.2 Market Forecast
  • 9.10 Pediatric
    • 9.10.1 Market Trends
    • 9.10.2 Market Forecast
  • 9.11 Others
    • 9.11.1 Market Trends
    • 9.11.2 Market Forecast

10 Market Breakup by Application

  • 10.1 Internal
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 External
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 Market Trends
    • 11.1.2 Market Forecast
  • 11.2 Europe
    • 11.2.1 Market Trends
    • 11.2.2 Market Forecast
  • 11.3 Asia Pacific
    • 11.3.1 Market Trends
    • 11.3.2 Market Forecast
  • 11.4 Middle East and Africa
    • 11.4.1 Market Trends
    • 11.4.2 Market Forecast
  • 11.5 Latin America
    • 11.5.1 Market Trends
    • 11.5.2 Market Forecast

12 Global Analgesics Industry: SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Global Analgesics Industry: Value Chain Analysis

  • 13.1 Overview
  • 13.2 Research and Development
  • 13.3 Raw Material Procurement
  • 13.4 Manufacturing
  • 13.5 Marketing
  • 13.6 Distribution
  • 13.7 End-Use

14 Global Analgesics Industry: Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Global Analgesics Industry: Price Analysis

  • 15.1 Price Indicators
  • 15.2 Price Structure
  • 15.3 Margin Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Bayer AG
    • 16.3.2 Novartis International AG
    • 16.3.3 GlaxoSmithKline PLC
    • 16.3.4 Pfizer Inc.
    • 16.3.5 Johnson & Johnson Pvt. Ltd.
    • 16.3.6 Reckitt Benckiser (RB) Group PLC
    • 16.3.7 Endo Pharmaceuticals PLC
    • 16.3.8 Bristol-Myers Squibb Company
    • 16.3.9 Eli Lilly and Company
    • 16.3.10 Sanofi SA

List of Figures

  • Figure 1: Global: Analgesics Market: Major Drivers and Challenges
  • Figure 2: Global: Analgesics Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Analgesics Market: Breakup by Type (in %), 2025
  • Figure 4: Global: Analgesics Market: Breakup by Drug Class (in %), 2025
  • Figure 5: Global: Analgesics Market: Breakup by Route of Administration (in %), 2025
  • Figure 6: Global: Analgesics Market: Breakup by Pain Type (in %), 2025
  • Figure 7: Global: Analgesics Market: Breakup by Application (in %), 2025
  • Figure 8: Global: Analgesics Market: Breakup by Region (in %), 2025
  • Figure 9: Global: Analgesics Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 10: Global: Analgesics Industry: SWOT Analysis
  • Figure 11: Global: Analgesics Industry: Value Chain Analysis
  • Figure 12: Global: Analgesics Industry: Porter's Five Forces Analysis
  • Figure 13: Global: Analgesics (Prescription) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Analgesics (Prescription) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Analgesics (Over the counter-OTC) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Analgesics (Over the counter-OTC) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Analgesics (Opioids) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Analgesics (Opioids) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Analgesics (NSAID) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Analgesics (NSAID) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Global: Analgesics (Others) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Global: Analgesics (Others) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: Global: Analgesics (Oral) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: Global: Analgesics (Oral) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Global: Analgesics (Parenteral) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Global: Analgesics (Parenteral) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: Global: Analgesics (Topical) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: Global: Analgesics (Topical) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: Global: Analgesics (Transdermal) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: Global: Analgesics (Transdermal) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: Global: Analgesics (Rectal) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: Global: Analgesics (Rectal) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: Global: Analgesics (Musculoskeletal) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: Global: Analgesics (Musculoskeletal) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: Global: Analgesics (Surgical and Trauma) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: Global: Analgesics (Surgical and Trauma) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: Global: Analgesics (Cancer) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: Global: Analgesics (Cancer) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: Global: Analgesics (Neuropathic) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: Global: Analgesics (Neuropathic) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: Global: Analgesics (Migraine) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: Global: Analgesics (Migraine) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: Global: Analgesics (Obstetrical) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: Global: Analgesics (Obstetrical) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: Global: Analgesics (Fibromyalgia) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: Global: Analgesics (Fibromyalgia) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: Global: Analgesics (Pain due to Burns) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: Global: Analgesics (Pain due to Burns) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: Global: Analgesics (Dental/Facial) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: Global: Analgesics (Dental/Facial) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: Global: Analgesics (Pediatric) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: Global: Analgesics (Pediatric) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: Global: Analgesics (Other Pain Types) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: Global: Analgesics (Other Pain Types) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: Global: Analgesics (Internal) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: Global: Analgesics (Internal) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: Global: Analgesics (External) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: Global: Analgesics (External) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: North America: Analgesics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: North America: Analgesics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: Europe: Analgesics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: Europe: Analgesics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: Asia Pacific: Analgesics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: Asia Pacific: Analgesics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: Middle East and Africa: Analgesics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 66: Middle East and Africa: Analgesics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 67: Latin America: Analgesics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 68: Latin America: Analgesics Market Forecast: Sales Value (in Million USD), 2026-2034

List of Tables

  • Table 1: Global: Analgesics Market: Key Industry Highlights, 2025 & 2034
  • Table 2: Global: Analgesics Market Forecast: Breakup by Type (in Million USD), 2026-2034
  • Table 3: Global: Analgesics Market Forecast: Breakup by Drug Class (in Million USD), 2026-2034
  • Table 4: Global: Analgesics Market Forecast: Breakup by Route of Administration (in Million USD), 2026-2034
  • Table 5: Global: Analgesics Market Forecast: Breakup by Pain Type (in Million USD), 2026-2034
  • Table 6: Global: Analgesics Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 7: Global: Analgesics Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 8: Global: Analgesics Market Structure
  • Table 9: Global: Analgesics Market: Key Players